BMRN vs VEEV · P/E 40, rev $1.76B vs P/E 27, rev $1.81B
Biomarin Pharmaceutical Inc (BMRN) versus Veeva Systems Inc Class A (VEEV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Veeva Systems Inc Class A (VEEV) is a health information services company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported VEEV revenue for 2026-07-31 was $1.81B. Net income was $534.4M. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
Not investment advice. Open the BMRN and VEEV stock pages for the full models.
Not investment advice.